US: 1.917.963.8646 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
Global Cell Counting Devices Market 2021: By type (Consumables & Accessories, Instruments), By end user (Hospitals, Diagnostic centers, Research institutions, Pharmaceutical, Biotechnology)Global Cell Counting Devices Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2028” is a recent report generated by Trusted Business Insights. The global cell counting devices market report has been segmented on the basis of type, end user, and region.Request Covid - 19 Impact The Global Cell Counting Devices market size was valued at USD $5.91 Billion in 2020, USD $6.31 Billion in 2021, forecasted to reach USD $6.73 Billion in 2022, and is projected to reach USD $13.73 Billion by 2030, and is anticipated to expand at a CAGR of 6.7% over the forecast period from 2020 to 2030.
Global Cell Counting Devices Market: OverviewCell counting devices are used to calculate concentration of blood cells such as white blood cells (WBCs) and red blood cells (RBCs) that are alive or dead. In addition, it is used to find bacteria and viruses present into the blood for further treatment. These devices help physicians to understand blood count, platelets, etc., and conduct diagnosis accordingly. Cell counting devices include cell counters, stream cytometers, spectrophotometers, microplates, hematology analyzers, and test packs. These devices are used in hospitals, research laboratories, biotechnology companies, and clinics for research, biopharmaceutical applications, drug delivery, etc.
Global Cell Counting Devices Market: DynamicsIncreasing prevalence of cancer, infectious, and chronic diseases such as typhoid, vector-borne diseases, malaria, poliomyelitis, etc., coupled with increasing demand for cell counting method for diagnosis is a key factor expected to drive growth of the global cell counting devices market over the forecast period. In addition, rising investment activities by various countries in order to improve healthcare infrastructure is another factor expected to further fuel growth of the target market over the forecast period. Moreover, increasing government investment for stem cell research is another factor expected to boost growth of the target market over the forecast period. Furthermore, technological advancements coupled with improved analysis and data visualization software and innovative product launches are some other factors expected to propel growth of the global market over the forecast period. However, high cost of advanced technology and increasing number of product recalls of hematology analyzers are major factors expected to restrain growth of the global market over the forecast period. Increasing focus on stem cell research and rising demand for cell counting instruments across various are of research includes cancer biology, neuroscience, and immunology are expected to create potential revenue opportunities for players operating in the target market over the forecast period. Rising adoption of various business strategies such as merger and acquisitions, new product launches, partnership, agreements, etc., by key players operating in the target market in order to improve its business and product offering along with geographical expansion is expected to support growth of the target market over the forecast period.
Global Cell Counting Devices Market: Segment AnalysisAmong the end user segments, the hospitals segment is expected to register significant growth market in terms of revenue over the forecast period, owing to rising adoption of cell counting equipment for treatment and diagnosis many diseases.
Global Cell Counting Devices Market: Regional AnalysisThe market in North America followed by Europe is expected to dominate in the global market in terms of revenue over the forecast period. This dominance can be attributed to improved healthcare infrastructure, rising government initiative for research and development activities across various countries in this region. In addition, presence of major key players such as Thermo Fisher Scientific, GE Healthcare, etc., is another factor expected to boost growth of the market in this region. The market in Asia Pacific is expected to register significant growth in terms of CAGR over the forecast period, owing to presence of clinical research companies, availability of skilled employees, and lower development costs across various countries in this region. CellDrop™, DirectPipette™, Slides™., EasyApps®, Scepter™, Instruments™, Invitrogen™, Countess™, Spark® are the brands covered in this Cell Counting Devices report.
Below are the active patents related to Cell Counting Devices Market.Patent Number: US8570370B2 Compact automated cell counter Abstract Biological cells in a liquid suspension are counted in an automated cell counter that focuses an image of the suspension on a digital imaging sensor that contains at least 4,000,000 pixels each having an area of 2×2 µm or less and that images a field of view of at least 3 mm2. The sensor enables the counter to compress the optical components into an optical path of less than 20 cm in height when arranged vertically with no changes in direction of the optical path as a whole, and the entire instrument has a footprint of less than 300 cm2. Activation of the light source, automated focusing of the sensor image, and digital cell counting are all initiated by the simple insertion of the sample holder into the instrument. The suspension is placed in a sample chamber in the form of a slide that is shaped to ensure proper orientation of the slide in the cell counter. Type: Grant Filed: 2010-08-27 Date of Patent: 2013-10-29 Assignee : Bio Rad Laboratories Inc Patent Number: US8852524B2 Cell counting slide with lateral reservoir for promoting uniform cell distribution Abstract Cells in a suspension are counted in a hemocytometer slice with a chamber of controlled depth and one or more reservoirs along one or more side edges of the chamber. The suspension is fed to a reservoir to first fill the reservoir, and then to overflow into the chamber. The result is an even distribution of the cells in the chamber. Type: Grant Filed: 2011-01-07 Date of Patent: 2014-10-07 Assignee : Bio Rad Laboratories Inc Patent Number: US20120003687A1 Methods for counting cells Abstract The invention features methods of quantifying cells in a sample by lysing the cells followed by the measurement of at least one intracellular component. Methods of the invention are especially useful for quantifying small numbers of cells, e.g., over a large surface area or volume compared to the cell size. In a preferred embodiment, methods of the invention are performed using a microfluidic device. Type: Grant Filed: 2008-04-21 Date of Patent: 2012-01-05 Assignee : General Hospital Corp , Purdue Research Foundation
Below are the leading companies profiled in this Cell Counting Devices Market Report:
Chapter 1 Methodology and Scope